| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/27/2004 | CA2069200C Crystalline acid addition salts of diastereomerically pure 1-(2,2-dimethylpropionyloxy)-ethyl-3-cephem-4-carboxylate |
| 01/26/2004 | CA2395871A1 Substituted indolealkanoic acids derivatives and formulations containing same for use in treatment of diabetic complications |
| 01/22/2004 | WO2004007493A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 01/22/2004 | WO2004007492A1 Novel macrocycles for the treatment of cancer |
| 01/22/2004 | WO2004007491A1 Azolidinone-vinyl fused-benzene derivatives |
| 01/22/2004 | WO2004007490A2 A process to prepare pioglitazone via several intermediates. |
| 01/22/2004 | WO2004007489A2 Antibacterial substituted cyanomethyl (ene) piperidinophenyl oxazolidinones, process or their preparation, and pharmaceutical compositions containing them |
| 01/22/2004 | WO2004007488A2 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them |
| 01/22/2004 | WO2004007483A1 Novel macrocycles for the treatment of cancer diseases |
| 01/22/2004 | WO2004007481A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 01/22/2004 | WO2004007476A1 Gesellschaft für biotechnologische forschung mbh (gbf) |
| 01/22/2004 | WO2004007461A1 8-hydroxy quinoline derivatives |
| 01/22/2004 | WO2004007458A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 01/22/2004 | WO2004007457A2 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | WO2004007407A2 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 01/22/2004 | WO2004006963A1 Conjugated infrared fluorescent substances for detection of cell death |
| 01/22/2004 | WO2004006924A1 Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol |
| 01/22/2004 | WO2004006923A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 01/22/2004 | WO2004006922A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 01/22/2004 | WO2004006846A2 Receptor-type kinase modulators and methods of use |
| 01/22/2004 | WO2003099206A3 Indole compounds useful as impdh inhibitors |
| 01/22/2004 | WO2003055447A3 Heterocyclic acridone inhibitors of impdh enzyme |
| 01/22/2004 | WO2002092573A3 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 01/22/2004 | US20040014979 For use as antitumor agents |
| 01/22/2004 | US20040014978 Such as (4S,7R,8S,9S,13(Z),16S(Z))-4,8-Dihydroxy-16-(1-fluoro-2-(2-methyl-4 -thiazolyl)ethenyl)-1-oxa-5,5,7,9,13-pentamethyl-cyclohexadec-13-ene-2,6 -dione |
| 01/22/2004 | US20040014977 Benzoxazole compound, process for producing the same, and herbicide |
| 01/22/2004 | US20040014967 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 01/22/2004 | US20040014903 Adhesion promoting compounds or resins containing a thiazole functionality (including benzothiazole) and a polymerizable functionality (Z) give improved adhesive strength to metal substrates. A representative structure is the following, in |
| 01/22/2004 | US20040014793 Stability in blood |
| 01/22/2004 | US20040014791 Hyperglycemic acid; antilipemic agents; antidiabetic agents |
| 01/22/2004 | US20040014790 Tartrate salt of thiazolidinedione derivative |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014776 Anticancer agents; cyclin-dependent kinase inhibitor |
| 01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 01/22/2004 | US20040014752 Antidiabetic agents; dietetics; hypoglycermic agents |
| 01/22/2004 | US20040014748 Cardiovascular disorders, central nervous susyem disorders |
| 01/22/2004 | US20040014746 Antimicrobial thiadiazinone derivatives and their application for treatment of bacterial infections |
| 01/22/2004 | DE10230874A1 Neue Tubulysinanaloga New Tubulysinanaloga |
| 01/22/2004 | CA2492743A1 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them |
| 01/22/2004 | CA2492194A1 Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoproteins sites |
| 01/22/2004 | CA2492164A1 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | CA2492100A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 01/22/2004 | CA2492045A1 Substituted amine derivatives and methods of use |
| 01/22/2004 | CA2491422A1 Novel macrocycles for the treatment of cancer diseases |
| 01/22/2004 | CA2491191A1 Receptor-type kinase modulators and methods of use |
| 01/21/2004 | EP1382604A1 Quinoline derivative having azolyl group and quinazoline derivative |
| 01/21/2004 | EP1382603A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF |
| 01/21/2004 | EP1382600A1 Curable compositions containing thiazole functionality |
| 01/21/2004 | EP1382598A1 Novel heterocyclic derivatives |
| 01/21/2004 | EP1382597A2 Steroid receptor modulator compounds and methods |
| 01/21/2004 | EP1382336A1 Abc expression promoters |
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
| 01/21/2004 | EP1381602A1 Heterocyclyldicarbamides as caspase inhibitors |
| 01/21/2004 | EP1381598A1 Novel tyrosine kinase inhibitors |
| 01/21/2004 | EP1381596A1 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents |
| 01/21/2004 | EP1381594A1 Urea compounds useful as anti-inflammatory agents |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | EP1381369A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence |
| 01/21/2004 | EP1381361A1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 01/21/2004 | EP1305028A4 Antimicrobial biaryl compounds |
| 01/21/2004 | EP1242415B1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 01/21/2004 | EP0948491B1 Aminothiazole derivatives useful in the preparation of beta-lactam antibiotics |
| 01/21/2004 | CN1469876A Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469873A Piperidine compounds as anti-allergic |
| 01/21/2004 | CN1469870A A process for the preparation of bis-benzazolyl compounds |
| 01/21/2004 | CN1469748A Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 01/21/2004 | CN1135229C Water soluble azoles as broad-spectrum antifungals |
| 01/21/2004 | CN1135223C Aryl-substd propanolamine derivate medicine containing them and their use |
| 01/20/2004 | US6680387 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| 01/20/2004 | US6680315 Compounds that down-regulate interleukin-12 production used for treating inflammatory diseases: rheumatoid arthritis, sepsis, chrohn's disease, multiple sclerosis, psoriasis or insulin-dependent diabetes |
| 01/20/2004 | US6680311 Cryptophycin compounds |
| 01/20/2004 | CA2303498C Dioxocyclopentyl hydroxamic acids |
| 01/20/2004 | CA2284795C Novel pyrimidine derivatives and processes for the preparation thereof |
| 01/20/2004 | CA2274621C New nitrone derivatives, their preparation method and pharmaceutical compositions comprising them |
| 01/20/2004 | CA2273181C 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo[d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function |
| 01/20/2004 | CA2223936C Novel substituted aryl and cycloalkyl imidazolones; a new class of gaba brain receptor ligands |
| 01/20/2004 | CA2174104C Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/20/2004 | CA2089441C Process for the preparation of cephem prodrug esters |
| 01/15/2004 | WO2004005327A1 Novel tubulysin analogues |
| 01/15/2004 | WO2004005284A1 Substituted 3-cyanoquinolines as mek inhibitors |
| 01/15/2004 | WO2004005283A1 Imidazoles, oxazoles and thiazoles with protein kinase inhibiting activities |
| 01/15/2004 | WO2004005281A1 Inhibitors of tyrosine kinases |
| 01/15/2004 | WO2004005279A2 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | WO2004005267A2 Heteroaryl compounds useful in treating inflammatory disorders |
| 01/15/2004 | WO2004005258A1 Di-aryl-substituted-ethane pyridone pde4 inhibitors |
| 01/15/2004 | WO2004005252A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | WO2004004727A1 3,4-dihydroisoquinolin-1-one derivatives as inducers of apoptosis |
| 01/15/2004 | WO2004004722A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | WO2004004720A1 3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 01/15/2004 | WO2004004629A2 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/15/2004 | US20040010143 Viricides |
| 01/15/2004 | US20040010030 Novel anti-infectives |
| 01/15/2004 | US20040010029 Also benzothiophene derivatives; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and infections; modulating T helper cells, Th1/ Th2, and inhibiting the transcription of IL-4 |
| 01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 01/15/2004 | US20040010010 Melanocortin receptor ligands |
| 01/15/2004 | US20040009995 Treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade |
| 01/15/2004 | US20040009991 Calcium channel antagonistic activity; especially useful as analgesics |